Our Investigators in the News

Tuberculosis Trials Consortium Clinical (2020-2030)

RI-MUHC is being awarded the Tuberculosis Trials Consortium Clinical from the Centers for Disease Control and Preventions (CDC) in the amount of $13.5 million USD.

The purpose of this procurement is to support clinical trials and clinical research on the treatment, diagnosis and prevention of tuberculosis . Emphasis will be given to studies of latent TB infection in low- and medium- TB incidence settings, inclusive of but not limited to the United States and Canada, as well as studies of active TB disease both domestically and internationally.

More information on the TBTC can be found here.

 

 

TB Centre Members Awarded 4-year CIHR Project Grant

Dr. Simon Grandjean Lapierre (PI), Dr. Marcel Behr (Co-I) and Dr. Kevin Schwartzman (Co-I) have been awarded a 4-year project grant from the Canadian Institutes of Health Research for their project titled “Tuberculosis Whole Genome Sequencing for Disease Control in Madagascar - A Cluster Randomized Controlled Trial to Evaluate Different Community-Level Strategies to Reduce the Burden of Disease”.

 

 

Some of our Award-winning Investigators

  • Dr Dick Menzies       

    Dr. Dick Menzies, Director of the Respiratory Epidemiology Unit at McGill and McGill’s World Health Organization Collaborating Centre in TB Research, has been named recipient of the 2019 CIHR-ICRH/CTS Distinguished Lecturer Award (DLA) in Respiratory Sciences.

    Each year, the DLA Series honours outstanding researchers within the Institute of Circulatory and Respiratory Health (ICRH) research community who have contributed significantly to the advancement of science in their field both in Canada and internationally. 

    Read more.

  • Dr Marcel Behr      

    Dr. Marcel Behr has been elected to Fellowship in the American Academy of Microbiology. The Academy recognizes excellence, originality, and leadership in the microbiological sciences. 

    Read more.

    He has also been elected as Tier 1 Canada Research Chair for Mycobacterial Genomics.

    Tier 1 Canada Research Chairs (CRC) are for outstanding researchers acknowledged by their peers as world leaders in their fields. A Chair is tenable for seven years and renewable once.

    Read more.

  • Dr Madhukar Pai                   

    Dr. Madhukar Pai serves as a Consultant to the Bill & Melinda Gates Foundation. He serves on the Scientific Advisory Committee of FIND, Geneva; and Access Advisory Committee of TB Alliance. He is on the editorial boards of Lancet Infectious Diseases, PLoS Medicine, eLife, PLoS ONE,  International Journal of TB and Lung Disease, among others.  

    He is a member of the Royal Society of Canada, and an elected Fellow of the Canadian Academy of Health Sciences. 

    Read more.

         

Back to top